Overview

ART Drug Dosage Adjustment in HIV-infected Population

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine efficacy of the combination of low dose of Tenofovir, Efavirenz and Lamivudine in treating HIV-infection.
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai Public Health Clinical Center
Treatments:
Efavirenz
Lamivudine
Tenofovir